Tiazac and Prolia drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Tiazac (diltiazem hydrochloride) and Prolia (denosumab). Common drug interactions include gastric disorder among females and joint swelling among males.

The phase IV clinical study analyzes what interactions people have when they take Tiazac and Prolia. It is created by eHealthMe based on reports of 38 people who take the same drugs from the FDA, and is updated regularly.

What is Tiazac?

Tiazac has active ingredients of diltiazem hydrochloride. It is often used in high blood pressure. eHealthMe is studying from 4,761 Tiazac users. Check the latest studies of Tiazac.

What is Prolia?

Prolia has active ingredients of denosumab. It is often used in osteoporosis. eHealthMe is studying from 151,388 Prolia users. Check the latest studies of Prolia.



On Jul, 26, 2026

38 people who take Tiazac and Prolia together, and have interactions are studied.

Tiazac and Prolia drug interactions.

What are the common drug interactions of Tiazac and Prolia, by gender? *:

female:

  1. Gastric disorder (disease of stomach)
  2. Gingival disorder (gum disease)
  3. Hepatitis (inflammation of the liver)
  4. Hypocalcaemia (levels of calcium in blood serum are abnormally low)
  5. Hypophosphataemia (electrolyte disturbance in which there is an abnormally low level of phosphate in the blood)
  6. Inflammation
  7. Pain
  8. Abdominal pain
  9. Fatigue (feeling of tiredness)
  10. Headache (pain in head)

male:

  1. Joint swelling
  2. Bladder cancer
  3. Nausea (feeling of having an urge to vomit)
  4. Rib fracture
  5. Transitional cell carcinoma (cancer tumour inner most layer of urinary system)
  6. Upper limb fracture
  7. Blood potassium decreased
  8. Bradycardia (abnormally slow heart action)
  9. Dehydration (dryness resulting from the removal of water)
  10. Haematoma (collection of blood outside the blood vessels)

What are the common drug interactions of Tiazac and Prolia, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

n/a

50-59:

  1. Dermatitis (inflammation of the skin resulting from direct irritation by an external agent or an allergic reaction to it)
  2. Feeling hot
  3. Headache (pain in head)
  4. Hot flush (sudden feelings of heat)
  5. Malaise (a feeling of general discomfort or uneasiness)
  6. Pain
  7. Pain in extremity
  8. Pain of skin
  9. Palpitations (feelings or sensations that your heart is pounding or racing)
  10. Peripheral swelling

60+:

  1. Abdominal pain
  2. Fatigue (feeling of tiredness)
  3. Nausea (feeling of having an urge to vomit)
  4. Cataract (clouding of the lens inside the eye)
  5. Chest discomfort
  6. Choking (mechanical obstruction of the flow of air from the environment into the lungs)
  7. Cough
  8. Fluid retention (an abnormal accumulation of fluid in the blood)
  9. Hypotension (abnormally low blood pressure)
  10. Localised oedema (fluid retention in a particular part of the body)

What are the existing conditions these people have? *

  1. Osteoporosis Post-Menopausal (weak bone with possibility to break after stopped menstrual cycles): 16 people, 42.11%
  2. Sleep Disorder: 3 people, 7.89%
  3. Pulmonary Hypertension (increase in blood pressure in the lung artery): 3 people, 7.89%
  4. Pain: 3 people, 7.89%
  5. Nausea (feeling of having an urge to vomit): 3 people, 7.89%
  6. Mantle Cell Lymphoma (cancer of lymphocytes, a type of white blood cell): 3 people, 7.89%
  7. Blood Iron Decreased: 3 people, 7.89%
  8. Atrial Fibrillation/flutter (atrial fibrillation and flutter are abnormal heart rhythms in which the atria, or upper chambers of the heart, are out of sync with the ventricles): 3 people, 7.89%
  9. Wheezing (a high-pitched whistling sound made while you breath): 2 people, 5.26%
  10. Rheumatoid Arthritis (a chronic progressive disease causing inflammation in the joints): 2 people, 5.26%

* Approximation only. Some reports may have incomplete information.

Do you take Tiazac and Prolia?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Tiazac and Prolia:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Tiazac:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Prolia:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Tiazac and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Prolia and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on diltiazem hydrochloride and denosumab (the active ingredients of Tiazac and Prolia, respectively), and Tiazac and Prolia (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: